987 related articles for article (PubMed ID: 23065479)
1. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F
Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479
[TBL] [Abstract][Full Text] [Related]
2. [Anti-basal ganglia antibody].
Hayashi M
Brain Nerve; 2013 Apr; 65(4):377-84. PubMed ID: 23568985
[TBL] [Abstract][Full Text] [Related]
3. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
Dale RC; Church AJ; Surtees RA; Lees AJ; Adcock JE; Harding B; Neville BG; Giovannoni G
Brain; 2004 Jan; 127(Pt 1):21-33. PubMed ID: 14570817
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor.
Mohammad SS; Sinclair K; Pillai S; Merheb V; Aumann TD; Gill D; Dale RC; Brilot F
Mov Disord; 2014 Jan; 29(1):117-22. PubMed ID: 24115338
[TBL] [Abstract][Full Text] [Related]
5. Antibody mediated encephalitis.
Ingram G; Robertson NP
J Neurol; 2013 Apr; 260(4):1187-90. PubMed ID: 23515700
[No Abstract] [Full Text] [Related]
6. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
Church AJ; Dale RC; Lees AJ; Giovannoni G; Robertson MM
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):602-7. PubMed ID: 12700302
[TBL] [Abstract][Full Text] [Related]
7. Reopening the case for anti-basal ganglia antibodies (ABGAs): identification of dopamine-2 receptor antibodies associated with movement disorders.
Balint B; Bhatia K
Mov Disord; 2013 Jun; 28(6):733. PubMed ID: 23801559
[No Abstract] [Full Text] [Related]
8. [Autoantibodies Associated with Autoimmune Basal Ganglia Disorders].
Sakuma H
Brain Nerve; 2018 Apr; 70(4):363-369. PubMed ID: 29632284
[TBL] [Abstract][Full Text] [Related]
9. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
Pathmanandavel K; Starling J; Merheb V; Ramanathan S; Sinmaz N; Dale RC; Brilot F
Biol Psychiatry; 2015 Mar; 77(6):537-47. PubMed ID: 25168608
[TBL] [Abstract][Full Text] [Related]
11. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
12. More movements in neuroimmunology.
Lim M; Vincent A
Brain; 2012 Nov; 135(Pt 11):3201-2. PubMed ID: 23169915
[No Abstract] [Full Text] [Related]
13. Autoantibody-associated movement disorders.
Mohammad SS; Ramanathan S; Brilot F; Dale RC
Neuropediatrics; 2013 Dec; 44(6):336-45. PubMed ID: 24203856
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders.
Sinmaz N; Tea F; Pilli D; Zou A; Amatoury M; Nguyen T; Merheb V; Ramanathan S; Cooper ST; Dale RC; Brilot F
Acta Neuropathol Commun; 2016 Dec; 4(1):126. PubMed ID: 27908295
[TBL] [Abstract][Full Text] [Related]
15. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies.
Dale RC; Church AJ; Cardoso F; Goddard E; Cox TC; Chong WK; Williams A; Klein NJ; Neville BG; Thompson EJ; Giovannoni G
Ann Neurol; 2001 Nov; 50(5):588-95. PubMed ID: 11706964
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry.
Sinmaz N; Amatoury M; Merheb V; Ramanathan S; Dale RC; Brilot F
Ann N Y Acad Sci; 2015 Sep; 1351():22-38. PubMed ID: 26083906
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea.
Ben-Pazi H; Stoner JA; Cunningham MW
PLoS One; 2013; 8(9):e73516. PubMed ID: 24073196
[TBL] [Abstract][Full Text] [Related]
18. Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease.
Cox CJ; Sharma M; Leckman JF; Zuccolo J; Zuccolo A; Kovoor A; Swedo SE; Cunningham MW
J Immunol; 2013 Dec; 191(11):5524-41. PubMed ID: 24184556
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
20. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
